---
title: Acromion Gmbh vs ProRelix Research
slug_a: acromion-gmbh
slug_b: prorelixresearch
site: cro
review_signal_gate: closed
canonical_path: /compare/acromion-gmbh/prorelixresearch
---

# Acromion Gmbh vs ProRelix Research

Side-by-side profile data from each company listing on this directory.

## Acromion Gmbh

- Profile: [/companies/acromion-gmbh](/companies/acromion-gmbh)

Acromion Gmbh — European full-service CRO supporting clinical development from Phase I to IV and non-interventional studies, with expertise in clinical monitoring, data management, biostatistics, medical writing, and regulatory affairs.

Services: 12. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (12).

### Services

- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- EU EMA Regulatory Strategy

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)

## ProRelix Research

- Profile: [/companies/prorelixresearch](/companies/prorelixresearch)

ProRelix Research — ProRelix Research supports Phase 1–4 clinical trials across pharmaceutical, biotechnology, and medical device sectors, offering clinical trial project management, data management, and medical writing services in compliance with ICH and GCP principles across the US, India, Europe, and Australia.

Services: 9. Modalities: 0. Indications: 0. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs

### Modalities

- Data not yet provided.

### Indications

- Data not yet provided.

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)